BR112012002077A2 - processos e métodos para diagnóstico de doença de alzheimer - Google Patents

processos e métodos para diagnóstico de doença de alzheimer

Info

Publication number
BR112012002077A2
BR112012002077A2 BR112012002077A BR112012002077A BR112012002077A2 BR 112012002077 A2 BR112012002077 A2 BR 112012002077A2 BR 112012002077 A BR112012002077 A BR 112012002077A BR 112012002077 A BR112012002077 A BR 112012002077A BR 112012002077 A2 BR112012002077 A2 BR 112012002077A2
Authority
BR
Brazil
Prior art keywords
disease
processes
methods
diagnosing alzheimer
alzheimer
Prior art date
Application number
BR112012002077A
Other languages
English (en)
Inventor
Pascale Beurdeley
Rich Einstein
Weiyin Zhou
Original Assignee
Exonhit Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exonhit Sa filed Critical Exonhit Sa
Publication of BR112012002077A2 publication Critical patent/BR112012002077A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR112012002077A 2009-07-31 2010-07-30 processos e métodos para diagnóstico de doença de alzheimer BR112012002077A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09305721A EP2287336A1 (fr) 2009-07-31 2009-07-31 Procédés et méthodes de diagnostic de la maladie d'Alzheimer
US25793409P 2009-11-04 2009-11-04
PCT/EP2010/061087 WO2011012691A2 (en) 2009-07-31 2010-07-30 Processes and methods for diagnosis of alzheimer's disease

Publications (1)

Publication Number Publication Date
BR112012002077A2 true BR112012002077A2 (pt) 2016-11-29

Family

ID=41649208

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012002077A BR112012002077A2 (pt) 2009-07-31 2010-07-30 processos e métodos para diagnóstico de doença de alzheimer

Country Status (8)

Country Link
US (1) US20120190577A1 (pt)
EP (2) EP2287336A1 (pt)
JP (1) JP2013500708A (pt)
CN (1) CN102597260A (pt)
AU (1) AU2010277532A1 (pt)
BR (1) BR112012002077A2 (pt)
CA (1) CA2768339A1 (pt)
WO (1) WO2011012691A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2723894B1 (en) 2011-06-27 2016-05-11 Eisai R&D Management Co., Ltd. Microrna biomarkers indicative of alzheimer's disease
CN107667293A (zh) * 2015-02-03 2018-02-06 法奈科斯公司 用于阿茲海默氏病的诊断工具
NZ743429A (en) * 2015-12-18 2022-02-25 Sangamo Therapeutics Inc Targeted disruption of the mhc cell receptor
US20190264264A1 (en) * 2016-10-26 2019-08-29 Integrated Nano-Technologies, Inc. Systems and methods for analyzing rna transcripts

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
FR2775984B1 (fr) 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20040265849A1 (en) * 2002-11-22 2004-12-30 Applera Corporation Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
WO2006099377A1 (en) * 2005-03-14 2006-09-21 Bg Medicine, Inc. Methods for detecting alzheimer's disease
US7771937B2 (en) * 2005-05-20 2010-08-10 University Of Washington Methods for predicting late onset Alzheimer disease in an individual
US7651840B2 (en) * 2006-07-14 2010-01-26 Celera Corporation Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
FR2929292A1 (fr) * 2008-03-28 2009-10-02 Exonhit Therapeutics S A Sa Procede et methodes de diagnostic de la maladie d'alzheimer

Also Published As

Publication number Publication date
EP2287336A1 (fr) 2011-02-23
US20120190577A1 (en) 2012-07-26
JP2013500708A (ja) 2013-01-10
WO2011012691A3 (en) 2011-03-24
WO2011012691A2 (en) 2011-02-03
AU2010277532A1 (en) 2012-02-16
CA2768339A1 (en) 2011-02-03
CN102597260A (zh) 2012-07-18
EP2459740A2 (en) 2012-06-06

Similar Documents

Publication Publication Date Title
BRPI0813212A2 (pt) Métodos de tratamento de doenças e distúrbios mediados por serotonina
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BR112012007164A2 (pt) "veículo"
EP2742155A4 (en) BIOMARKER FOR ALZHEIMER'S DISEASE AND / OR COGNITIVE LIGHT DISORDER, AND USE THEREOF
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
BR112012004593A2 (pt) "método"
ME01898B (me) Metoda za identifikaciju faktora rizika od alchajmerove bolesti
BRPI1013015A2 (pt) "osteosíntese com nanoprata"
BRPI0917567A2 (pt) tratamento de doença respiratória
FI20115576A0 (fi) Menetelmä Alzheimerin taudin diagnoimiseksi
BR112014008089A2 (pt) método para diagnosticar o mal de alzheimer, uso do método, e, kit para a realização do método
ZA201404500B (en) Methods for diagnosing alzheimer's disease
BRPI1014595A2 (pt) procedimento de obtenção de novos derivados naftaleno para o diagnóstico in vivo de doença de alzheimer
EP2485733A4 (en) METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
BRPI0810559A2 (pt) Macadores de doenças
BR112012003844A2 (pt) vacinas de pttv e diagnóstico
EP2136211A4 (en) PROCEDURE FOR ALLERGIC DISEASE
BRPI1013671A2 (pt) método para o diagnóstico de endometriose e kit de diagnóstico para endometriose
BR112014000637A2 (pt) diagnóstico do mal de alzheimer
DK2245463T3 (da) Diagnostisk fremgangsmåde
EP2791676A4 (en) PROCESS FOR THE DIAGNOSIS OF MORBUS ALZHEIMER
BR112012002077A2 (pt) processos e métodos para diagnóstico de doença de alzheimer
BRPI0918279A2 (pt) método de diagnóstico e kit de diagnóstico para dermatomiosite
EP2660600A4 (en) DIAGNOSTIC MEDICINE AND DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]